Friday, January 14, 2022 5:58:50 PM
Vikinginvest, we don't know if back in October, when Dr. Bosch's presentation was scheduled, whether it was planned as a victory lap because NWBO believed that TLD/publication would be out before January 20 or whether the presentation was supposed to be an overview of past, present and future GBM treatments with TLD/publication thought to be some months away.
If the presentation was supposed to be a victory lap, why now issue the cancellation a mere 5 days prior to the talk? A logical reason for taking this step would be if NWBO believed until today that the results would be PRd before January 20 and very recently realized that TLD/publication would be delayed till after January 20.
OTOH if during October, Dr. Bosch's presentation was planned to discuss
the history and future of GBM treatment with the expectation that the results of the trial (TLD/publication) would still be pending, again why issue a cancellation now, 5 days before the presentation unless they believe that TLD/presentation will be with us shortly before the presentation or shortly thereafter. In that case a more general presentation topic would no longer be relevant.
In either case, a victory lap or a an overview of GBM treatment, the cancellation of the presentation on such short notice suggests that perhaps we are very close to TLD/publication.
Of course there may have been other reasons for this on short notice cancellation such as illness, an emergency or a number of other reasons.
Just speculating here like everybody.
If the presentation was supposed to be a victory lap, why now issue the cancellation a mere 5 days prior to the talk? A logical reason for taking this step would be if NWBO believed until today that the results would be PRd before January 20 and very recently realized that TLD/publication would be delayed till after January 20.
OTOH if during October, Dr. Bosch's presentation was planned to discuss
the history and future of GBM treatment with the expectation that the results of the trial (TLD/publication) would still be pending, again why issue a cancellation now, 5 days before the presentation unless they believe that TLD/presentation will be with us shortly before the presentation or shortly thereafter. In that case a more general presentation topic would no longer be relevant.
In either case, a victory lap or a an overview of GBM treatment, the cancellation of the presentation on such short notice suggests that perhaps we are very close to TLD/publication.
Of course there may have been other reasons for this on short notice cancellation such as illness, an emergency or a number of other reasons.
Just speculating here like everybody.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
